Fenbendazole Exhibits Differential Anticancer Effects In Vitro and In Vivo in Models of Mouse Lymphoma. (2023)

Peer-Reviewed Study · Haebeen Jung; Si-Yeon Kim; Hong-Gu Joo · November 8, 2023

Haebeen Jung et al., 2023-11-08: Jung et al. find fenbendazole arrests EL-4 lymphoma cells in G2/M in culture but has no antitumour effect in an EL-4 mouse lymphoma model, with tumour growth comparable to control.

However, FBZ had no anticancer effects on an EL-4 mouse lymphoma model in vivo, as evident by rapid weight loss and tumor growth comparable to the control.

Haebeen Jung et al., 2023-11-08: Jung et al. find fenbendazole arrests EL-4 lymphoma cells in G2/M in culture but has no antitumour effect in an EL-4 mouse lymphoma model, with tumour growth comparable to control. Study type: EL-4 mouse T lymphoma cells in vitro plus an EL-4-bearing mouse model. N: not stated in the abstract; groups of 7-10-week-old and 17-21-week-old mice. Country: Korea (Konkuk University). Dose: 25 mg/kg intraperitoneally on days 0, 3 and 6; 40 mg/kg increased tumour weight and the dose was reduced (full text). Funder: not stated in the record. Declared conflicts: 'The authors declare no conflict of interest.' Comparator: vehicle and CHOP (40 mg/kg). The paper also reports higher PD-L1 and CD86 on treated cells and more M2 macrophages in treated tumours. Study type: animal.